Profile: Fred Hassan, pharma titan, gooseberry picker and secret geography geek
This article was originally published in Scrip
Executive Summary
Fred Hassan, partner and managing director at Warburg Pincus, was CEO of Schering-Plough until 2009 when it merged with Merck & Co. He then joined Warburg Pincus and was chairman of eye care firm Bausch + Lomb until its sale in 2013. Before joining Schering-Plough in 2003, Mr Hassan was chairman and CEO of Pharmacia, and he previously held senior executive positions at Wyeth and Sandoz.